Translations are automatically made by Google translate.
We apologize for any inaccuracies.

VersaTron® Non-Invasive Treatment Delivers Significant Results with Low Risk

Non-Invasive

As a non-invasive technology, VersaTron® allows animals to receive treatment with minimal recovery time. The non-invasive nature eliminates the need for a sterile environment and the risk of infection. In addition to reducing risk to the patient, non-invasive VersaTron® also reduces client cost when compared to invasive procedures.

Excellent Safety Profile

Because VersaTron® is non-invasive, it does not produce scar tissue and avoids the potential morbidity and mortality associated with traditional surgical procedures. Additionally, its use does not preclude subsequent surgical treatment.

VersaTron® is the preferred shock wave device of leading equine practitioners and has been proven safe and effective in more equine studies and clinical trials than any other shock wave system. VersaTron® provides prompt symptom improvement with significant results generally seen within 10 days posttreatment. Additionally, unlike non-electrohydraulic devices, VersaTron® provides true shock waves at all energy levels and the treatment focal area increases as energy increases, thereby helping to ensure the most effective treatment possible.

Mechanism of Action

VersaTron® treatment aids in healing by stimulating the body’s regeneration process. The focused high-energy shock wave used in VersaTron® travels through the skin and soft tissues. Energy is released as a shock wave at tissue interfaces where the density of the tissue or impedance of the sound waves changes. These changes of impedance occur where soft tissue, tendons, ligaments, cartilage, and bone meet. The energy released leads to a cellular reaction that causes the release of various substances including BMP-2, eNOS, VEGF, and PCNA. Neovascularization takes place, leading to increased blood supply to the treated tissue, resulting in tissue regeneration in tendons, joints, and bone.

VersaTron® Applications & Administration

VersaTron® is recommended for the management of a variety of musculoskeletal disorders causing pain and lameness in horses. VersaTron® can be used in combination with anti-inflammatory drugs, surgical intervention, and physical treatment. Shock wave treatment is beneficial for the following applications in the equine population:

  • Suspensory Ligament
  • Tendonitis or Tenosynovitis
  • Stable Stress Fractures
  • Tendon Avulsion and Avulsion Fractures
  • Periostitis
  • Proximal Splint Bone Fractures
  • Hock Degenerative Joint Disease
  • Sacroiliac
  • Lumbosacral
  • Sesamoiditis

Customized Treatment

The 5 mm, 20 mm, 35 mm and 80 mm VersaTrodes allow shock waves to penetrate to different depths while various energy settings for each Trode allow further customization. The software allows the practitioner to choose the number and pace of shocks to be administered.

Administration is Easy for the Practitioner and Easy on the Patient

Candidates for VersaTron® treatment should undergo a full physical exam with blood and urine analyses to evaluate overall health and anesthetic risk. A complete orthopedic and neurologic exam is essential for diagnosing musculoskeletal pathology and ruling out any underlying neurological disease. The treatment is usually carried out with the animal in the standing position. Preparation of the treatment area is minimal and requires clipping of the horse’s hair to the size of the membrane of the treatment head and cleaning the area with alcohol. In most cases only mild sedation is required. Most treatments take 10-20 minutes including preparation. When implementing shock wave treatment, it is essential to treat all regions that appear to be painful to ensure best results. Clinical results prove that the best outcomes are obtained when the focus is directed on the area between the soft tissue and the bone, as well as directly on the joint itself. Coupling gel must be used and the shock wave treatment applicator should be moved in a continuous, level movement over the region of interest and the surrounding tissue.

Owning a Non-Invasive VersaTron® is Simple and Cost-Effective

Simple Administration. The handheld VersaTrode applicator allows easy access to treatment areas and the menu-guided software is user-friendly.

Cost-Efficient. The shock wave generation principle ensures high efficiency with a low rate of repeat treatments and the device pays for itself with less than 5 treatments administered per month*.

Low Maintenance. VersaTron® is easy to clean and the compact model allows for portability and easy storage.

* Based upon lease with 60 month term.


Treatment Precautions: Treatments should NOT be directed at gas-filled cavities, such as lungs or intestines, or the head area as serious injuries may result.

Warning: ESWT produces a series of loud noises which may be frightening or painful to animals undergoing treatment. An animal’s reaction to the device may vary with the area being treated. In some cases, sedation may be required for safe restraint.

Precaution: A post-treatment period of analgesia is known to exist following ESWT. Extra care must be taken to ensure the underlying musculoskeletal disorders have improved enough to allow increased exercise.

Caution: Federal law restricts this device to sale by or on the order of a licensed veterinarian.